United States· US:61480-255_440c889d-1e85-767e-e063-6394a90abaa8
Psorizide Forte
A medicinal product containing nickel sulfate; potassium bromide; fumaric acid, registered in United States by PLYMOUTH HEALTHCARE PRODUCTS LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- NICKEL SULFATE; POTASSIUM BROMIDE; FUMARIC ACID
- Manufacturer
- PLYMOUTH HEALTHCARE PRODUCTS LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1161480-255-05
- ndc11614802550590 TABLET in 1 BOTTLE (61480-255-05)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e12768d4-84f4-4e33-959b-dfd00707bdc5 GET /v1/drugs/e12768d4-84f4-4e33-959b-dfd00707bdc5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "1; 1; 1",
"substance": "NICKEL SULFATE; POTASSIUM BROMIDE; FUMARIC ACID",
"productndc": "61480-255",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "[hp_X]/1; [hp_X]/1; [hp_X]/1",
"application_number": null,
"marketing_category": "UNAPPROVED HOMEOPATHIC"
}See everything about nickel sulfate; potassium bromide; fumaric acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.